Absorption |
Blood-Brain Barrier | BBB+ | 0.7556 |
Human Intestinal Absorption | HIA- | 0.7742 |
Caco-2 Permeability | Caco2- | 0.8557 |
P-glycoprotein Substrate | Non-substrate | 0.5420 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8440 |
Non-inhibitor | 0.9359 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8801 |
Distribution |
Subcellular localization | Mitochondria | 0.6869 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8735 |
CYP450 2D6 Substrate | Non-substrate | 0.8468 |
CYP450 3A4 Substrate | Non-substrate | 0.6516 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9171 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9340 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9390 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8889 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9753 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9677 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9734 |
Non-inhibitor | 0.8118 |
AMES Toxicity | Non AMES toxic | 0.9123 |
Carcinogens | Non-carcinogens | 0.9397 |
Fish Toxicity | Low FHMT | 0.6355 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.5584 |
Honey Bee Toxicity | High HBT | 0.7382 |
Biodegradation | Not ready biodegradable | 0.7256 |
Acute Oral Toxicity | IV | 0.5641 |
Carcinogenicity (Three-class) | Non-required | 0.6367 |